Intellia Therapeutics Receives Backing of UK Health Regulator to Conduct Trial of Gene Therapy

intellia therapeutics获得英国卫生监管机构支持进行基因治疗试验

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登录免费看全文